Last reviewed · How we verify
NCT06105034
Placenta Accreta Spectrum Disorder Conservative Managment Versus Hysterectomy Prospective Analysis
trial testing interventional techniques, the severity of placental invasion, and various placental positions and suture techniques in Placenta Accreta in 300 participants. Completed in 1 September 2023.
1 September 2023
Quick facts
| Lead sponsor | Nourhan Elsadany |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 March 2022 |
| Primary completion | 1 September 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- interventional techniques, the severity of placental invasion, and various placental positions and suture techniques
Conditions studied
- Placenta Accreta — all drugs for Placenta Accreta →
Sponsor
Nourhan Elsadany
Who can join
Adults 18 to 40, female only, with Placenta Accreta. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to identify risk factors associated with performing cesarean hysterectomy versus conservative management in patients with placenta accreta spectrum (PAS). Research question What are the risk factors associated with cesarean hysterectomy in patients with placenta accreta spectrum? Research hypothesis There are certain risk factors associated with cesarean hysterectomy in patients with Placenta accreta spectrum (PAS).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06105034
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Placenta Accreta
Currently open trials in the same condition.
- NCT07283042 — Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum · recruiting
- NCT06465836 — Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef University · NA · recruiting
- NCT06185894 — Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery · NA · recruiting
- NCT06833606 — Diagnosis and Outcomes of Placental Accretism · recruiting
- NCT05922397 — Placenta Accreta Spectrum Topographic Classification · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06105034 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nourhan Elsadany
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06105034.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing